Lumentum (LITE) Financials

$1,001.81 -28.56 (-2.77%)

Closing price 04:00 PM Eastern

Extended Trading

$994.40 -7.41 (-0.74%)

As of 04:57 PM Eastern

Annual Income Statements for Lumentum

This table shows Lumentum's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	7/2/2016	7/1/2017	6/30/2018	6/29/2019	6/27/2020	7/3/2021	7/2/2022	7/1/2023	6/29/2024	6/28/2025
Net Income / (Loss) Attributable to Common Shareholders	-3.40	-3.20	-103	242	-38	136	397	199	-132	-547	26
Consolidated Net Income / (Loss)	-3.40	9.30	-103	248	-36	136	397	199	-132	-547	26
Net Income / (Loss) Continuing Operations	-3.40	9.30	-103	248	-36	136	397	199	-132	-547	26
Total Pre-Tax Income	-25	9.70	-60	129	-33	174	463	235	-102	-406	-172
Total Operating Income	-23	12	48	140	-22	204	527	303	-116	-434	-180
Total Gross Profit	258	277	318	432	426	650	783	789	569	252	460
Total Revenue	837	903	1,002	1,248	1,565	1,679	1,743	1,713	1,767	1,359	1,645
Operating Revenue	837	903	1,002	1,248	1,565	1,679	1,743	1,713	1,767	1,359	1,645
Total Cost of Revenue	579	626	684	816	1,139	1,028	960	924	1,198	1,108	1,185
Operating Cost of Revenue	579	626	684	816	1,139	1,028	960	924	1,198	1,108	1,185
Total Operating Expenses	281	266	271	292	448	446	256	485	685	686	640
Selling, General & Admin Expense	129	117	110	128	200	235	241	266	349	311	348
Research & Development Expense	141	141	148	157	185	199	215	221	308	302	304
Restructuring Charge	12	7.40	12	7.20	32	8.00	7.70	-1.10	28	73	23
Other Special Charges / (Income)	-	-	-	-	-	-	-	-	0.00	0.00	-35
Total Other Income / (Expense), net	-1.10	-1.80	-107	-11	-12	-30	-64	-68	13	28	8.00
Interest Expense	-	-	5.50	18	36	61	67	80	36	34	22
Other Income / (Expense), net	-1.10	-1.80	-102	7.70	25	31	2.80	12	49	62	30
Income Tax Expense	-21	0.40	43	-119	3.10	39	66	36	29	141	-198
Basic Earnings per Share	($0.06)	($0.05)	($1.71)	$3.88	($0.54)	$1.79	$5.27	$2.79	($1.93)	($8.12)	$0.38
Weighted Average Basic Shares Outstanding	58.80M	59.10M	60.60M	62.30M	70.70M	75.90M	75.40M	71.20M	68.30M	67.30M	69M
Diluted Earnings per Share	($0.06)	($0.05)	($1.71)	$3.82	($0.54)	$1.75	$5.07	$2.68	($1.93)	($8.12)	$0.37
Weighted Average Diluted Shares Outstanding	58.80M	59.10M	60.60M	63.30M	70.70M	77.60M	78.40M	74.20M	68.30M	67.30M	69.60M
Weighted Average Basic & Diluted Shares Outstanding	56.70M	64M	60.50M	62.20M	76.90M	75.20M	72.70M	68.10M	66.70M	68M	69.90M

This table shows Lumentum's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
Net Income / (Loss) Attributable to Common Shareholders	-68	-99	-127	-253	-82	-61	-44	213	4.20	78	143
Consolidated Net Income / (Loss)	-68	-99	-127	-253	-82	-61	-44	213	4.20	78	144
Net Income / (Loss) Continuing Operations	-68	-99	-127	-253	-82	-61	-44	213	4.20	78	144
Total Pre-Tax Income	-69	-102	-107	-128	-79	-42	-39	-11	5.20	97	184
Total Operating Income	-81	-105	-115	-133	-82	-52	-38	-8.40	6.70	64	175
Total Gross Profit	77	64	60	51	78	100	123	160	182	240	357
Total Revenue	318	367	367	308	337	402	425	481	534	666	808
Operating Revenue	318	367	367	308	337	402	425	481	534	666	808
Total Cost of Revenue	241	303	307	257	259	303	303	321	352	425	451
Operating Cost of Revenue	241	303	307	257	259	303	303	321	352	425	451
Total Operating Expenses	158	169	174	185	160	151	160	168	175	176	183
Selling, General & Admin Expense	73	85	78	75	76	76	112	84	85	96	91
Research & Development Expense	74	78	77	73	74	74	76	80	81	80	91
Restructuring Charge	11	5.80	19	37	9.70	0.70	7.20	5.20	8.30	-0.40	1.10
Other Special Charges / (Income)	-	-	0.00	-	-	0.00	-35	-	-	-	0.00
Total Other Income / (Expense), net	12	3.70	7.20	5.90	3.20	9.30	-1.50	-3.00	-1.50	32	9.30
Interest Expense	9.70	9.70	9.00	5.40	5.50	5.60	5.70	5.40	5.70	6.30	6.20
Other Income / (Expense), net	21	13	16	11	8.70	15	4.20	2.40	4.20	39	16
Income Tax Expense	-1.40	-2.40	20	125	3.20	19	4.90	-225	1.00	18	40
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	0.00	-	-	-	1.70
Basic Earnings per Share	($1.02)	($1.47)	($1.88)	($3.75)	($1.21)	($0.88)	($0.64)	$3.11	$0.06	$1.10	$1.99
Weighted Average Basic Shares Outstanding	66.70M	67.20M	67.50M	67.30M	68.30M	68.90M	69.30M	69M	70.30M	71.10M	71.50M
Diluted Earnings per Share	($1.02)	($1.47)	($1.88)	($3.75)	($1.21)	($0.88)	($0.64)	$3.10	$0.05	$0.89	$1.50
Weighted Average Diluted Shares Outstanding	66.70M	67.20M	67.50M	67.30M	68.30M	68.90M	69.30M	69.60M	78.30M	87.80M	96.20M
Weighted Average Basic & Diluted Shares Outstanding	67M	67.40M	67.60M	68M	68.70M	69.20M	69.40M	69.90M	70.90M	71.40M	77.80M

This table details how cash moves in and out of Lumentum's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	7/2/2016	7/1/2017	6/30/2018	6/29/2019	6/27/2020	7/3/2021	7/2/2022	7/1/2023	6/29/2024	6/28/2025
Net Change in Cash & Equivalents	-5.40	143	116	124	35	-135	476	516	-431	-422	84
Net Cash From Operating Activities	9.40	87	85	248	330	524	739	459	180	25	126
Net Cash From Continuing Operating Activities	9.40	87	85	248	330	524	739	459	180	25	126
Net Income / (Loss) Continuing Operations	-3.40	9.30	-103	248	-36	136	397	199	-132	-547	26
Consolidated Net Income / (Loss)	-3.40	9.30	-103	248	-36	136	397	199	-132	-547	26
Depreciation Expense	43	47	54	74	103	113	91	82	107	111	104
Amortization Expense	8.00	7.20	12	20	128	124	146	158	191	203	155
Non-Cash Adjustments To Reconcile Net Income	16	26	29	48	93	98	114	105	166	123	160
Changes in Operating Assets and Liabilities, net	-54	-2.80	92	-142	43	54	-9.80	-84	-152	135	-320
Net Cash From Investing Activities	-54	-82	-426	-127	-780	-988	1.00	-226	-874	-114	-84
Net Cash From Continuing Investing Activities	-54	-82	-426	-127	-780	-988	1.00	-226	-874	-114	-84
Purchase of Property, Plant & Equipment	-54	-82	-138	-93	-167	-90	-95	-91	-129	-133	-231
Acquisitions	0.00	0.00	-5.10	0.00	-620	-	0.00	0.00	-862	-705	0.00
Purchase of Investments	0.00	0.00	-291	-634	-270	-1,341	-1,991	-1,115	-1,030	-279	-366
Sale of Property, Plant & Equipment	0.20	-	0.00	0.00	0.00	0.00	23	6.40	0.30	0.80	48
Sale and/or Maturity of Investments	0.00	0.00	8.20	601	252	424	2,062	974	1,146	1,002	465
Net Cash From Financing Activities	41	136	457	3.80	485	329	-263	283	263	-333	42
Net Cash From Continuing Financing Activities	41	136	457	3.80	485	329	-263	283	263	-333	42
Repayment of Debt	0.00	-2.30	0.00	-6.40	-2.50	-498	0.00	-1.80	-139	-323	-8.10
Repurchase of Common Equity	-	-	-	0.00	0.00	-200	-236	-544	-176	0.00	0.00
Issuance of Debt	0.00	0.00	442	0.00	491	1,042	0.00	854	599	0.00	77
Issuance of Common Equity	41	137	8.10	9.20	9.30	9.90	13	14	15	14	16
Other Financing Activities, net	0.00	1.90	7.20	1.70	-12	-26	-40	-39	-37	-24	-43
Cash Interest Paid	-	0.00	0.00	1.30	15	13	6.40	7.50	11	20	19
Cash Income Taxes Paid	-	2.70	9.50	13	8.70	7.60	50	57	67	61	21

This table details how cash moves in and out of Lumentum's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
Net Change in Cash & Equivalents	2.60	-392	-44	12	53	-9.50	37	4.30	252	-115	1,960
Net Cash From Operating Activities	-2.30	-1.50	-7.00	36	40	24	-1.60	64	58	127	204
Net Cash From Continuing Operating Activities	-2.30	-1.50	-7.00	36	40	24	-1.60	64	58	127	204
Net Income / (Loss) Continuing Operations	-68	-99	-127	-253	-82	-61	-44	213	4.20	78	144
Consolidated Net Income / (Loss)	-68	-99	-127	-253	-82	-61	-44	213	4.20	78	144
Depreciation Expense	28	27	27	28	27	26	25	26	28	31	33
Amortization Expense	34	42	51	72	44	40	36	35	35	35	35
Non-Cash Adjustments To Reconcile Net Income	32	26	34	34	41	34	39	46	43	55	43
Changes in Operating Assets and Liabilities, net	-28	1.60	7.80	154	10	-14	-58	-258	-52	-72	-51
Net Cash From Investing Activities	18	-395	290	-28	-47	-31	53	-59	-68	-231	-182
Net Cash From Continuing Investing Activities	18	-395	290	-28	-47	-31	53	-59	-68	-231	-182
Purchase of Property, Plant & Equipment	-58	-31	-20	676	-74	-40	-63	-54	-76	-84	-125
Purchase of Investments	-149	-35	-34	-60	-64	-127	-90	-86	-58	-199	-122
Sale of Property, Plant & Equipment	0.00	0.20	0.60	-	0.20	-	48	-	0.00	0.10	40
Sale and/or Maturity of Investments	228	372	345	57	91	136	158	80	67	51	63
Net Cash From Financing Activities	-13	4.10	-328	3.70	60	-3.10	-15	-0.30	262	-11	1,938
Net Cash From Continuing Financing Activities	-13	4.10	-328	3.70	60	-3.10	-15	-0.30	262	-11	1,938
Repayment of Debt	0.00	-	-323	-	-0.40	-2.50	-2.50	-2.70	-846	-4.60	-5.20
Issuance of Common Equity	-	-	-	7.10	-	-	0.20	7.80	-	-	0.50
Other Financing Activities, net	-13	-3.20	-4.50	-3.40	-16	-8.70	-13	-5.40	-148	-62	-57
Cash Interest Paid	0.60	9.30	0.50	9.30	0.10	9.40	0.20	9.40	0.10	10	2.50
Cash Income Taxes Paid	19	3.70	30	8.70	-4.20	-2.70	17	10	3.20	15	23

This table presents Lumentum's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	7/2/2016	7/1/2017	6/30/2018	6/29/2019	6/27/2020	7/3/2021	7/2/2022	7/1/2023	6/29/2024	6/28/2025
Total Assets	513	726	1,233	1,582	2,717	3,293	3,552	4,162	4,632	3,932	4,219
Total Current Assets	311	490	930	1,127	1,333	2,050	2,437	3,139	2,778	1,590	1,717
Cash & Equivalents	15	157	273	397	433	298	774	1,290	859	437	521
Short-Term Investments	-	0.00	282	314	336	1,256	1,172	1,259	1,155	450	356
Inventories, net	100	101	145	174	229	189	196	250	409	398	470
Prepaid Expenses	46	61	64	45	98	74	82	78	110	110	120
Other Current Assets	-	-	-	-	-	-	-	-	-	-	250
Plant, Property, & Equipment, net	143	183	274	307	433	0.00	0.00	361	490	573	726
Total Noncurrent Assets	59	53	29	147	951	1,243	1,115	663	1,365	1,769	1,775
Goodwill	27	20	22	11	369	369	369	369	695	1,056	1,061
Intangible Assets	-	-	-	7.00	395	317	241	156	459	618	465
Noncurrent Deferred & Refundable Income Taxes	30	32	3.90	126	170	81	73	27	116	11	210
Other Noncurrent Operating Assets	0.90	1.60	3.70	3.50	17	476	432	111	94	85	39
Total Liabilities & Shareholders' Equity	513	726	1,233	1,582	2,717	3,293	3,552	4,162	4,632	3,932	4,219
Total Liabilities	132	193	578	620	1,220	1,543	1,579	2,287	3,276	2,975	3,084
Total Current Liabilities	122	174	184	214	294	283	665	717	634	269	393
Short-Term Debt	-	-	-	0.00	5.00	0.00	391	410	312	0.00	11
Accounts Payable	78	118	115	127	161	151	117	157	169	126	225
Accrued Expenses	12	15	19	34	47	24	33	45	51	52	35
Current Employee Benefit Liabilities	18	27	28	32	42	53	54	55	39	36	58
Other Current Liabilities	11	12	23	22	39	55	70	51	62	55	65
Total Noncurrent Liabilities	9.80	19	394	406	926	1,260	914	1,571	2,643	2,705	2,691
Long-Term Debt	-	0.00	318	334	836	1,120	790	1,466	2,500	2,503	2,563
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	0.30	56	47	36	13	3.40	56	7.20
Other Noncurrent Operating Liabilities	9.80	19	77	71	34	94	89	92	139	146	121
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	381	497	619	926	1,497	1,749	1,973	1,875	1,356	957	1,135
Total Preferred & Common Equity	381	497	619	926	1,497	1,749	1,973	1,875	1,356	957	1,135
Preferred Stock	-	-	-	-	-	-	-	-	-	-	0.00
Total Common Equity	381	497	619	926	1,497	1,749	1,973	1,875	1,356	957	1,135
Common Stock	0.00	468	695	753	1,361	1,677	1,744	2,004	1,692	1,835	1,987
Retained Earnings	0.00	20	-83	166	129	65	221	-129	-341	-887	-861
Accumulated Other Comprehensive Income / (Loss)	13	9.40	7.40	6.40	7.10	7.90	8.20	0.40	4.10	9.30	9.00

This table presents Lumentum's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2022	4/1/2023	9/30/2023	12/30/2023	3/30/2024	9/28/2024	12/28/2024	3/29/2025	9/27/2025	12/27/2025	3/28/2026
Total Assets	4,418	4,354	4,545	4,656	4,205	3,970	3,966	3,975	4,613	4,805	7,028
Total Current Assets	2,493	2,464	2,692	2,062	1,650	1,636	1,651	1,667	2,086	2,283	4,396
Cash & Equivalents	592	549	862	469	425	489	480	516	773	658	2,618
Short-Term Investments	1,088	1,118	1,083	755	446	427	417	350	349	498	555
Accounts Receivable	-	278	-	-	-	-	-	256	307	377	442
Inventories, net	367	410	428	472	421	403	402	423	532	570	633
Prepaid Expenses	115	108	99	118	129	118	126	122	125	181	149
Plant, Property, & Equipment, net	488	483	512	582	579	638	663	693	795	814	964
Total Noncurrent Assets	1,438	1,408	1,342	2,012	1,976	1,695	1,651	1,614	1,733	1,709	1,668
Goodwill	698	696	695	1,055	1,056	1,061	1,061	1,061	1,061	1,061	1,066
Intangible Assets	540	498	435	731	689	574	535	500	431	397	363
Noncurrent Deferred & Refundable Income Taxes	100	116	128	130	139	13	11	13	205	206	198
Other Noncurrent Operating Assets	100	97	83	96	92	48	45	41	37	45	41
Total Liabilities & Shareholders' Equity	4,418	4,354	4,545	4,656	4,205	3,970	3,966	3,975	4,613	4,805	7,028
Total Liabilities	2,875	2,816	3,234	3,378	3,028	3,074	3,094	3,096	3,832	3,959	4,055
Total Current Liabilities	814	769	594	658	318	305	347	353	1,526	3,768	3,865
Short-Term Debt	421	426	316	320	0.00	11	9.80	10	1,079	3,240	3,239
Accounts Payable	206	199	135	163	133	163	185	195	279	347	393
Accrued Expenses	62	60	59	66	62	40	46	44	46	39	49
Current Employee Benefit Liabilities	61	41	41	50	40	42	40	43	69	85	110
Other Current Liabilities	65	43	43	60	82	50	66	61	54	56	75
Total Noncurrent Liabilities	2,060	2,047	2,641	2,720	2,710	2,769	2,747	2,743	2,306	191	189
Long-Term Debt	1,900	1,901	2,501	2,502	2,502	2,569	2,561	2,562	2,165	47	43
Noncurrent Deferred & Payable Income Tax Liabilities	26	18	13	68	62	53	45	39	6.00	5.60	5.40
Other Noncurrent Operating Liabilities	134	129	127	151	146	146	140	141	136	138	141
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,544	1,538	1,311	1,278	1,177	896	872	880	781	847	2,973
Total Preferred & Common Equity	1,544	1,538	1,311	1,278	1,177	896	872	880	781	847	2,973
Preferred Stock	-	-	-	-	-	-	-	-	-	-	0.00
Total Common Equity	1,544	1,538	1,311	1,278	1,177	896	872	880	781	847	2,973
Common Stock	1,642	1,672	1,714	1,776	1,803	1,854	1,893	1,943	1,629	1,616	3,601
Retained Earnings	-101	-141	-409	-508	-635	-970	-1,030	-1,075	-857	-779	-635
Accumulated Other Comprehensive Income / (Loss)	3.40	7.10	5.20	9.20	8.80	12	10	11	9.10	9.40	7.00

This table displays calculated financial ratios and metrics derived from Lumentum's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	7/2/2016	7/1/2017	6/30/2018	6/29/2019	6/27/2020	7/3/2021	7/2/2022	7/1/2023	6/29/2024	6/28/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.35%	7.87%	10.92%	24.57%	25.45%	7.24%	3.82%	-1.73%	3.18%	-23.08%	21.03%
EBITDA Growth	-51.47%	142.64%	-81.65%	1,946.61%	-3.27%	102.40%	62.25%	-27.68%	-58.40%	-125.43%	287.05%
EBIT Growth	-350.00%	139.59%	-659.79%	371.82%	-97.97%	7,750.00%	124.97%	-40.49%	-121.22%	-455.90%	59.69%
NOPAT Growth	-272.44%	167.31%	202.20%	705.02%	-105.64%	1,149.38%	184.95%	-43.25%	-131.56%	-275.11%	58.50%
Net Income Growth	-131.78%	373.53%	-1,202.15%	342.05%	-114.67%	472.25%	193.21%	-49.94%	-166.16%	-315.27%	104.74%
EPS Growth	-133.33%	16.67%	-3,320.00%	323.39%	-114.14%	424.07%	189.71%	-47.14%	-172.01%	-320.73%	104.56%
Operating Cash Flow Growth	-85.03%	821.28%	-1.85%	191.18%	33.37%	58.83%	40.89%	-37.82%	-60.85%	-86.26%	411.34%
Free Cash Flow Firm Growth	78.19%	101.54%	-819.46%	1,460.86%	-1,095.72%	141.25%	35.89%	-53.28%	-494.35%	29.95%	47.01%
Invested Capital Growth	15.96%	2.73%	10.82%	40.26%	168.47%	-16.17%	-8.24%	-0.44%	79.18%	19.49%	10.00%
Revenue Q/Q Growth	0.00%	3.77%	-1.86%	6.70%	7.08%	-2.13%	1.40%	1.78%	-2.82%	-4.40%	11.71%
EBITDA Q/Q Growth	0.00%	90.24%	-71.77%	43.49%	3.27%	2.69%	1.91%	4.34%	-25.72%	-569.60%	173.13%
EBIT Q/Q Growth	0.00%	149.49%	-205.06%	85.43%	-94.88%	20.58%	3.11%	5.73%	-304.59%	-30.13%	43.65%
NOPAT Q/Q Growth	0.00%	219.33%	-11.52%	1.27%	-178.12%	17.82%	7.66%	6.56%	-2,529.55%	-21.74%	40.97%
Net Income Q/Q Growth	0.00%	144.71%	-207.81%	55.35%	-258.95%	18.55%	7.03%	7.11%	-258.58%	-54.29%	105.89%
EPS Q/Q Growth	0.00%	91.07%	-210.91%	72.85%	-205.88%	21.53%	7.42%	8.06%	-257.41%	-54.37%	105.71%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	10.99%	37.54%	-0.94%	0.20%	-2.11%	-26.58%	-35.68%	29.14%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-104.82%	324.55%	4.10%	15.39%	4.94%	-16.51%	-3.36%	15.87%	-4,299.01%
Invested Capital Q/Q Growth	0.00%	5.85%	73.74%	6.39%	-2.61%	-5.26%	-5.28%	0.03%	-2.00%	-8.36%	9.49%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.81%	30.71%	31.76%	34.63%	27.21%	38.73%	44.93%	46.05%	32.20%	18.50%	27.96%
EBITDA Margin	3.17%	7.12%	1.18%	19.36%	14.92%	28.17%	44.02%	32.40%	13.06%	-4.32%	6.67%
Operating Margin	-2.80%	1.27%	4.75%	11.21%	-1.38%	12.16%	30.24%	17.71%	-6.55%	-31.93%	-10.95%
EBIT Margin	-2.93%	1.07%	-5.42%	11.83%	0.19%	14.03%	30.40%	18.41%	-3.79%	-27.36%	-9.11%
Profit (Net Income) Margin	-0.41%	1.03%	-10.23%	19.88%	-2.33%	8.07%	22.80%	11.61%	-7.45%	-40.21%	1.57%
Tax Burden Percent	13.88%	95.88%	171.40%	191.73%	109.31%	77.74%	85.79%	84.60%	128.52%	134.71%	-15.05%
Interest Burden Percent	100.00%	100.00%	110.13%	87.67%	-1,110.00%	74.01%	87.41%	74.56%	153.06%	109.09%	114.81%
Effective Tax Rate	0.00%	4.12%	0.00%	-91.73%	0.00%	22.26%	14.21%	15.40%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-4.80%	2.97%	8.40%	53.57%	-1.40%	11.00%	35.84%	21.30%	-4.83%	-12.85%	-4.67%
ROIC Less NNEP Spread (ROIC-NNEP)	-80.27%	4.98%	77.19%	60.12%	12.55%	23.83%	44.98%	29.32%	-85.80%	-32.96%	4.51%
Return on Net Nonoperating Assets (RNNOA)	3.86%	-0.94%	-25.66%	-22.88%	-1.56%	-2.65%	-14.49%	-10.96%	-3.32%	-34.40%	7.14%
Return on Equity (ROE)	-0.95%	2.04%	-17.26%	30.70%	-2.96%	8.35%	21.35%	10.34%	-8.15%	-47.25%	2.48%
Cash Return on Invested Capital (CROIC)	-19.59%	0.28%	-1.86%	20.06%	-92.85%	28.59%	44.43%	21.74%	-61.55%	-30.61%	-14.19%
Operating Return on Assets (OROA)	-4.88%	1.57%	-5.54%	10.49%	0.14%	7.84%	15.48%	8.18%	-1.52%	-8.69%	-3.68%
Return on Assets (ROA)	-0.68%	1.50%	-10.46%	17.63%	-1.69%	4.51%	11.61%	5.16%	-2.99%	-12.76%	0.64%
Return on Common Equity (ROCE)	-0.95%	1.96%	-16.22%	29.34%	-2.92%	8.35%	21.35%	10.34%	-8.15%	-47.25%	2.48%
Return on Equity Simple (ROE_SIMPLE)	-0.89%	1.87%	-16.56%	26.79%	-2.43%	7.75%	20.14%	10.61%	-9.71%	-57.09%	0.00%
Net Operating Profit after Tax (NOPAT)	-16	11	33	268	-15	159	452	257	-81	-304	-126
NOPAT Margin	-1.96%	1.22%	3.33%	21.50%	-0.97%	9.45%	25.94%	14.98%	-4.58%	-22.35%	-7.66%
Net Nonoperating Expense Percent (NNEP)	75.47%	-2.01%	-68.79%	-6.55%	-13.96%	-12.83%	-9.14%	-8.02%	80.98%	20.11%	-9.18%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	-3.40%
Cost of Revenue to Revenue	69.19%	69.29%	68.24%	65.37%	72.79%	61.27%	55.07%	53.95%	67.80%	81.50%	72.04%
SG&A Expenses to Revenue	15.40%	12.99%	11.00%	10.27%	12.80%	14.01%	13.85%	15.51%	19.74%	22.86%	21.17%
R&D to Revenue	16.82%	15.63%	14.81%	12.57%	11.79%	11.83%	12.31%	12.89%	17.42%	22.23%	18.47%
Operating Expenses to Revenue	33.60%	29.44%	27.01%	23.42%	28.59%	26.58%	14.69%	28.34%	38.75%	50.43%	38.91%
Earnings before Interest and Taxes (EBIT)	-25	9.70	-54	148	3.00	236	530	315	-67	-372	-150
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	27	64	12	242	234	473	767	555	231	-59	110
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	2.82	5.64	3.91	2.73	3.26	3.21	2.86	2.87	3.60	5.80
Price to Tangible Book Value (P/TBV)	0.00	2.94	5.84	3.99	5.57	5.36	4.65	3.98	19.34	0.00	0.00
Price to Revenue (P/Rev)	0.00	1.55	3.48	2.91	2.61	3.40	3.64	3.14	2.21	2.53	4.00
Price to Earnings (P/E)	0.00	0.00	0.00	15.01	0.00	42.08	15.95	27.00	0.00	0.00	253.89
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	6.66%	0.00%	2.38%	6.27%	3.70%	0.00%	0.00%	0.39%
Enterprise Value to Invested Capital (EV/IC)	0.00	3.41	7.89	5.62	2.65	4.00	4.61	3.91	2.18	1.97	2.92
Enterprise Value to Revenue (EV/Rev)	0.00	1.42	3.28	2.63	2.65	3.14	3.20	2.74	2.66	3.72	5.03
Enterprise Value to EBITDA (EV/EBITDA)	0.00	19.92	278.53	13.59	17.78	11.14	7.26	8.47	20.34	0.00	75.33
Enterprise Value to EBIT (EV/EBIT)	0.00	132.03	0.00	22.24	1,384.31	22.37	10.51	14.90	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	116.15	98.64	12.24	0.00	33.21	12.32	18.30	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	14.79	38.67	13.26	12.58	10.05	7.54	10.23	26.11	204.79	65.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1,248.50	0.00	32.69	0.00	12.77	9.94	17.93	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.49	0.35	0.56	0.64	0.60	1.00	2.07	2.61	2.27
Long-Term Debt to Equity	0.00	0.00	0.49	0.35	0.56	0.64	0.40	0.78	1.84	2.61	2.26
Financial Leverage	-0.05	-0.19	-0.33	-0.38	-0.12	-0.11	-0.32	-0.37	0.04	1.04	1.58
Leverage Ratio	1.40	1.36	1.65	1.74	1.75	1.85	1.84	2.00	2.72	3.70	3.90
Compound Leverage Factor	1.40	1.36	1.82	1.53	-19.40	1.37	1.61	1.49	4.17	4.04	4.47
Debt to Total Capital	0.00%	0.00%	32.66%	25.79%	35.97%	39.04%	37.44%	50.01%	67.47%	72.34%	69.40%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.21%	0.00%	12.39%	10.93%	7.48%	0.00%	0.29%
Long-Term Debt to Total Capital	0.00%	0.00%	32.66%	25.79%	35.75%	39.04%	25.05%	39.09%	59.99%	72.34%	69.11%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	6.71%	3.68%	2.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	93.29%	63.66%	71.45%	64.03%	60.96%	62.56%	49.99%	32.53%	27.66%	30.60%
Debt to EBITDA	0.00	0.00	26.91	1.38	3.60	2.37	1.54	3.38	12.18	-42.64	23.44
Net Debt to EBITDA	0.00	0.00	-20.15	-1.56	0.31	-0.92	-1.00	-1.21	3.46	-27.53	15.45
Long-Term Debt to EBITDA	0.00	0.00	26.91	1.38	3.58	2.37	1.03	2.64	10.83	-42.64	23.34
Debt to NOPAT	0.00	0.00	9.53	1.25	-55.62	7.06	2.61	7.31	-34.72	-8.24	-20.41
Net Debt to NOPAT	0.00	0.00	-7.14	-1.41	-4.79	-2.73	-1.69	-2.62	-9.85	-5.32	-13.45
Long-Term Debt to NOPAT	0.00	0.00	9.53	1.25	-55.28	7.06	1.75	5.71	-30.87	-8.24	-20.33
Altman Z-Score	0.00	6.20	4.92	5.45	3.11	3.63	4.08	2.73	1.50	0.82	1.64
Noncontrolling Interest Sharing Ratio	0.00%	3.92%	6.03%	4.43%	1.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.54	2.82	5.05	5.27	4.53	7.24	3.67	4.38	4.38	5.90	4.37
Quick Ratio	1.35	1.89	3.92	4.25	3.42	6.32	3.25	3.92	3.57	3.29	2.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-67	1.03	-7.38	100	-1,000	412	561	262	-1,033	-724	-383
Operating Cash Flow to CapEx	17.57%	105.61%	61.55%	265.56%	197.31%	582.56%	1,033.15%	541.63%	140.25%	18.68%	69.05%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-1.34	5.52	-27.55	6.74	8.40	3.27	-29.09	-21.41	-17.27
Operating Cash Flow to Interest Expense	0.00	0.00	15.45	13.60	9.09	8.57	11.08	5.73	5.06	0.73	5.69
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-9.65	8.48	4.48	7.10	10.00	4.67	1.45	-3.18	-2.55
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.67	1.46	1.02	0.89	0.73	0.56	0.51	0.44	0.40	0.32	0.40
Accounts Receivable Turnover	5.83	5.63	5.95	6.87	7.20	7.12	7.81	7.21	6.96	0.00	7.40
Inventory Turnover	5.90	6.25	5.56	5.11	5.66	4.92	4.98	4.14	3.64	2.75	2.73
Fixed Asset Turnover	5.99	5.53	4.38	4.30	4.23	0.00	0.00	0.00	4.16	2.56	2.53
Accounts Payable Turnover	7.24	6.38	5.86	6.76	7.93	6.60	7.17	6.75	7.35	7.49	6.74
Days Sales Outstanding (DSO)	62.57	64.88	61.37	53.15	50.73	51.26	46.74	50.60	52.48	0.00	49.34
Days Inventory Outstanding (DIO)	61.82	58.42	65.63	71.45	64.53	74.13	73.27	88.19	100.34	132.96	133.75
Days Payable Outstanding (DPO)	50.41	57.23	62.24	53.99	46.02	55.30	50.91	54.04	49.68	48.72	54.13
Cash Conversion Cycle (CCC)	73.98	66.07	64.76	70.61	69.24	70.09	69.10	84.75	103.15	84.24	128.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	366	376	417	585	1,570	1,316	1,207	1,202	2,154	2,574	2,831
Invested Capital Turnover	2.46	2.43	2.53	2.49	1.45	1.16	1.38	1.42	1.05	0.58	0.61
Increase / (Decrease) in Invested Capital	50	10	41	168	985	-254	-108	-5.30	952	420	257
Enterprise Value (EV)	0.00	1,281	3,287	3,283	4,153	5,269	5,570	4,697	4,695	5,058	8,272
Market Capitalization	0.00	1,402	3,489	3,625	4,081	5,702	6,335	5,370	3,897	3,442	6,576
Book Value per Share	$6.47	$8.39	$10.12	$14.79	$19.60	$23.35	$25.99	$27.17	$19.74	$14.16	$16.35
Tangible Book Value per Share	$6.01	$8.05	$9.77	$14.50	$9.59	$14.20	$17.95	$19.57	$2.93	($10.59)	($5.64)
Total Capital	381	533	972	1,296	2,338	2,870	3,153	3,751	4,167	3,461	3,708
Total Debt	0.00	0.00	318	334	841	1,120	1,181	1,876	2,812	2,503	2,573
Total Long-Term Debt	0.00	0.00	318	334	836	1,120	790	1,466	2,500	2,503	2,563
Net Debt	-15	-157	-238	-377	72	-434	-766	-673	798	1,616	1,696
Capital Expenditures (CapEx)	54	82	138	93	167	90	72	85	128	132	183
Debt-free, Cash-free Net Working Capital (DFCFNWC)	174	159	191	202	275	213	217	284	442	434	458
Debt-free Net Working Capital (DFNWC)	189	316	746	913	1,044	1,767	2,163	2,833	2,456	1,321	1,335
Net Working Capital (NWC)	189	316	746	913	1,039	1,767	1,772	2,423	2,144	1,321	1,325
Net Nonoperating Expense (NNE)	-13	1.73	136	20	21	23	55	58	51	243	-152
Net Nonoperating Obligations (NNO)	-15	-157	-238	-377	72	-434	-766	-673	798	1,616	1,696
Total Depreciation and Amortization (D&A)	51	55	66	94	231	237	237	240	298	313	260
Debt-free, Cash-free Net Working Capital to Revenue	20.80%	17.57%	19.05%	16.17%	17.59%	12.70%	12.45%	16.56%	25.02%	31.92%	27.84%
Debt-free Net Working Capital to Revenue	22.53%	34.97%	74.49%	73.19%	66.68%	105.27%	124.10%	165.40%	138.98%	97.17%	81.16%
Net Working Capital to Revenue	22.53%	34.97%	74.49%	73.19%	66.36%	105.27%	101.69%	141.46%	121.34%	97.17%	80.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.06)	($0.05)	($1.71)	$3.88	($0.54)	$1.79	$5.27	$2.79	($1.93)	($8.12)	$0.38
Adjusted Weighted Average Basic Shares Outstanding	58.92M	59.10M	60.60M	62.30M	70.70M	75.90M	75.40M	71.20M	68.30M	67.30M	69M
Adjusted Diluted Earnings per Share	($0.06)	($0.05)	($1.71)	$3.82	($0.54)	$1.75	$5.07	$2.68	($1.93)	($8.12)	$0.37
Adjusted Weighted Average Diluted Shares Outstanding	58.92M	59.10M	60.60M	63.30M	70.70M	77.60M	78.40M	74.20M	68.30M	67.30M	69.60M
Adjusted Basic & Diluted Earnings per Share	($0.06)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.80M	60.08M	61.52M	63.30M	76.90M	75.20M	72.70M	68.10M	66.70M	68M	69.90M
Normalized Net Operating Profit after Tax (NOPAT)	-8.26	18	42	103	29	168	459	256	-61	-253	-135
Normalized NOPAT Margin	-0.99%	2.01%	4.17%	8.25%	1.83%	10.02%	26.32%	14.93%	-3.47%	-18.61%	-8.18%
Pre Tax Income Margin	-2.93%	1.07%	-5.97%	10.37%	-2.13%	10.38%	26.57%	13.73%	-5.80%	-29.85%	-10.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-9.87	8.11	0.08	3.85	7.94	3.93	-1.88	-11.00	-6.75
NOPAT to Interest Expense	0.00	0.00	6.06	14.74	-0.42	2.59	6.78	3.20	-2.28	-8.99	-5.68
EBIT Less CapEx to Interest Expense	0.00	0.00	-34.98	2.99	-4.53	2.38	6.87	2.87	-5.50	-14.91	-14.99
NOPAT Less CapEx to Interest Expense	0.00	0.00	-19.05	9.62	-5.03	1.12	5.71	2.14	-5.89	-12.90	-13.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	5.38%	0.88%	0.28%	-1.92%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	5.38%	0.88%	0.28%	-1.92%	147.60%	59.40%	273.45%	-133.43%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Lumentum's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	71,400,000.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	71,400,000.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2.00
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-37.33%	-27.51%	-4.41%	-16.86%	6.08%	9.65%	16.02%	55.92%	58.44%	65.46%	90.12%
EBITDA Growth	-97.35%	-136.94%	-174.36%	-145.01%	-196.00%	230.63%	208.73%	504.35%	3,179.17%	481.03%	840.51%
EBIT Growth	-318.32%	-404.40%	-146.00%	-239.17%	-23.66%	60.02%	65.96%	95.09%	114.79%	380.11%	667.16%
NOPAT Growth	-19,591.26%	-380.37%	-122.96%	-138.64%	-1.98%	50.95%	67.10%	93.70%	109.38%	244.26%	618.77%
Net Income Growth	-16,875.00%	-212.62%	-223.16%	-319.44%	-21.35%	38.55%	65.28%	184.48%	105.10%	228.41%	426.98%
EPS Growth	-10,100.00%	-219.57%	-229.82%	-321.35%	-18.63%	40.14%	65.96%	182.67%	104.13%	201.14%	334.38%
Operating Cash Flow Growth	-111.06%	-101.58%	-146.98%	-27.85%	1,821.74%	1,720.00%	77.14%	80.28%	46.21%	421.40%	12,837.50%
Free Cash Flow Firm Growth	98.03%	22.66%	33.08%	48.22%	-2,253.09%	138.25%	128.43%	48.71%	22.35%	-229.89%	-283.64%
Invested Capital Growth	-1.72%	31.64%	27.77%	19.49%	17.26%	-11.43%	-7.93%	10.00%	13.39%	16.96%	19.24%
Revenue Q/Q Growth	-14.35%	15.49%	-0.08%	-15.88%	9.28%	19.38%	5.72%	13.05%	11.05%	24.67%	21.47%
EBITDA Q/Q Growth	-94.91%	-988.00%	-7.98%	-8.87%	89.14%	1,308.33%	-5.52%	103.65%	32.44%	128.01%	52.94%
EBIT Q/Q Growth	-65.56%	-54.03%	-7.19%	-24.09%	39.64%	50.20%	8.72%	82.09%	281.67%	843.12%	84.82%
NOPAT Q/Q Growth	-44.54%	-30.20%	-8.94%	-16.40%	38.23%	37.38%	26.94%	77.72%	192.03%	862.87%	162.74%
Net Income Q/Q Growth	-12.79%	-45.95%	-28.15%	-98.82%	67.37%	26.09%	27.59%	583.67%	-98.03%	1,761.90%	84.40%
EPS Q/Q Growth	-14.61%	-44.12%	-27.89%	-99.47%	67.73%	27.27%	27.27%	584.38%	-98.39%	1,680.00%	68.54%
Operating Cash Flow Q/Q Growth	-104.67%	34.78%	-366.67%	607.14%	11.55%	-38.64%	-106.58%	4,100.00%	-9.53%	118.83%	60.85%
Free Cash Flow Firm Q/Q Growth	98.14%	-4,042.15%	9.68%	25.71%	15.34%	167.33%	-32.88%	-234.06%	-28.16%	-12.63%	5.11%
Invested Capital Q/Q Growth	1.36%	31.70%	-2.33%	-8.36%	-0.53%	-0.52%	1.53%	9.49%	2.53%	2.62%	3.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.15%	17.45%	16.23%	16.64%	23.12%	24.76%	28.81%	33.26%	34.00%	36.08%	44.16%
EBITDA Margin	0.79%	-6.05%	-5.54%	-7.17%	-0.71%	7.21%	6.44%	11.61%	13.84%	25.32%	31.88%
Operating Margin	-25.44%	-28.68%	-31.27%	-43.27%	-24.46%	-12.83%	-8.87%	-1.75%	1.26%	9.66%	21.59%
EBIT Margin	-18.77%	-25.03%	-26.85%	-39.60%	-21.88%	-9.12%	-7.88%	-1.25%	2.04%	15.45%	23.50%
Profit (Net Income) Margin	-21.38%	-27.02%	-34.65%	-81.90%	-24.46%	-15.14%	-10.37%	44.37%	0.79%	11.75%	17.84%
Tax Burden Percent	97.98%	97.64%	118.25%	198.04%	104.04%	143.97%	112.50%	-1,871.05%	80.77%	81.04%	78.45%
Interest Burden Percent	116.28%	110.57%	109.15%	104.42%	107.46%	115.26%	117.01%	190.00%	47.71%	93.87%	96.74%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	19.23%	18.96%	21.55%
Return on Invested Capital (ROIC)	-12.76%	-11.42%	-12.43%	-17.42%	-9.95%	-4.68%	-3.39%	-0.74%	0.68%	5.97%	14.87%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.21%	-13.69%	-16.52%	-30.60%	-11.90%	-6.20%	-4.45%	12.49%	0.62%	7.34%	15.67%
Return on Net Nonoperating Assets (RNNOA)	-7.85%	-10.86%	-13.94%	-31.94%	-13.68%	-9.43%	-7.22%	19.78%	1.40%	16.25%	7.39%
Return on Equity (ROE)	-20.61%	-22.28%	-26.37%	-49.35%	-23.63%	-14.12%	-10.61%	19.03%	2.08%	22.21%	22.25%
Cash Return on Invested Capital (CROIC)	-4.95%	-35.43%	-34.36%	-30.61%	-28.74%	2.26%	0.34%	-14.19%	-14.88%	-11.20%	-4.12%
Operating Return on Assets (OROA)	-6.63%	-7.94%	-8.92%	-12.57%	-7.08%	-2.99%	-2.84%	-0.50%	0.88%	7.41%	10.63%
Return on Assets (ROA)	-7.55%	-8.57%	-11.51%	-26.00%	-7.92%	-4.97%	-3.73%	17.91%	0.34%	5.64%	8.07%
Return on Common Equity (ROCE)	-20.61%	-22.28%	-26.37%	-49.35%	-23.63%	-14.12%	-10.61%	19.03%	2.08%	22.21%	22.25%
Return on Equity Simple (ROE_SIMPLE)	-15.19%	-20.86%	-30.10%	0.00%	-62.62%	-59.93%	-50.02%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-57	-74	-80	-93	-58	-36	-26	-5.88	5.41	52	137
NOPAT Margin	-17.81%	-20.08%	-21.89%	-30.29%	-17.12%	-8.98%	-6.21%	-1.22%	1.01%	7.83%	16.94%
Net Nonoperating Expense Percent (NNEP)	1.45%	2.28%	4.08%	13.18%	1.95%	1.51%	1.06%	-13.23%	0.06%	-1.37%	-0.80%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.80%	-	-	-	-1.05%	-0.76%	-0.16%	0.13%	1.26%	2.19%
Cost of Revenue to Revenue	75.85%	82.55%	83.77%	83.36%	76.88%	75.24%	71.19%	66.74%	66.00%	63.92%	55.84%
SG&A Expenses to Revenue	22.98%	23.20%	21.20%	24.29%	22.65%	18.97%	26.34%	17.39%	15.94%	14.44%	11.23%
R&D to Revenue	23.14%	21.35%	21.06%	23.74%	22.05%	18.45%	17.85%	16.54%	15.25%	12.04%	11.21%
Operating Expenses to Revenue	49.59%	46.13%	47.50%	59.91%	47.58%	37.59%	37.68%	35.01%	32.75%	26.42%	22.58%
Earnings before Interest and Taxes (EBIT)	-60	-92	-98	-122	-74	-37	-34	-6.00	11	103	190
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2.50	-22	-20	-22	-2.40	29	27	56	74	169	258
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.30	2.75	2.71	3.60	4.90	6.64	4.92	5.80	14.39	32.73	16.87
Price to Tangible Book Value (P/TBV)	16.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	32.49
Price to Revenue (P/Rev)	1.91	2.44	2.24	2.53	3.18	4.10	2.94	4.00	6.10	13.16	20.16
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	253.89	99.88	110.12	114.50
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.39%	1.00%	0.91%	0.87%
Enterprise Value to Invested Capital (EV/IC)	1.78	1.78	1.72	1.97	2.36	2.93	2.33	2.92	4.60	10.02	16.31
Enterprise Value to Revenue (EV/Rev)	2.46	3.55	3.39	3.72	4.39	5.28	4.10	5.03	7.25	14.17	20.21
Enterprise Value to EBITDA (EV/EBITDA)	27.96	90.12	385.83	0.00	0.00	0.00	150.16	75.33	71.78	91.64	90.46
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	402.12	168.91
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	243.37	132.15
Enterprise Value to Operating Cash Flow (EV/OCF)	24.80	84.74	125.60	204.79	90.87	80.84	61.72	65.49	92.38	120.80	111.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	122.06	661.18	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.15	2.21	2.13	2.61	2.88	2.95	2.93	2.27	4.15	3.88	1.10
Long-Term Debt to Equity	1.91	1.96	2.13	2.61	2.87	2.94	2.91	2.26	2.77	0.06	0.01
Financial Leverage	0.55	0.79	0.84	1.04	1.15	1.52	1.62	1.58	2.26	2.21	0.47
Leverage Ratio	3.15	3.22	3.15	3.70	3.86	4.01	3.98	3.90	5.12	5.10	2.86
Compound Leverage Factor	3.66	3.56	3.44	3.87	4.15	4.62	4.65	7.40	2.44	4.79	2.76
Debt to Total Capital	68.24%	68.83%	68.02%	72.34%	74.23%	74.67%	74.52%	69.40%	80.60%	79.52%	52.47%
Short-Term Debt to Total Capital	7.65%	7.80%	0.00%	0.00%	0.31%	0.28%	0.30%	0.29%	26.81%	78.38%	51.77%
Long-Term Debt to Total Capital	60.59%	61.03%	68.02%	72.34%	73.91%	74.38%	74.23%	69.11%	53.79%	1.14%	0.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	31.76%	31.17%	31.98%	27.66%	25.77%	25.33%	25.48%	30.60%	19.40%	20.48%	47.53%
Debt to EBITDA	20.26	49.76	200.19	-42.64	-40.57	-207.34	64.00	23.44	17.43	10.10	5.90
Net Debt to EBITDA	6.28	28.17	130.52	-27.53	-26.16	-135.02	42.44	15.45	11.40	6.55	0.20
Long-Term Debt to EBITDA	17.99	44.12	200.19	-42.64	-40.40	-206.55	63.74	23.34	11.63	0.14	0.08
Debt to NOPAT	-19.16	-13.74	-10.03	-8.24	-8.46	-9.61	-12.05	-20.41	-50.92	26.81	8.62
Net Debt to NOPAT	-5.93	-7.78	-6.54	-5.32	-5.46	-6.26	-7.99	-13.45	-33.31	17.39	0.29
Long-Term Debt to NOPAT	-17.01	-12.19	-10.03	-8.24	-8.43	-9.58	-12.00	-20.33	-33.98	0.38	0.11
Altman Z-Score	1.29	1.08	1.06	1.02	1.20	1.48	1.20	1.76	2.05	4.11	7.83
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.53	3.13	5.20	5.90	5.36	4.76	4.72	4.37	1.37	0.61	1.14
Quick Ratio	3.27	1.86	2.74	3.29	3.00	2.58	3.18	2.87	0.94	0.41	0.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-18	-765	-691	-513	-434	292	196	-263	-337	-380	-360
Operating Cash Flow to CapEx	-3.98%	-4.87%	-36.84%	0.00%	53.59%	60.45%	-10.74%	118.74%	75.98%	151.74%	239.20%
Free Cash Flow to Firm to Interest Expense	-1.90	-78.83	-76.74	-95.01	-78.98	52.23	34.44	-48.74	-59.17	-60.30	-58.14
Operating Cash Flow to Interest Expense	-0.24	-0.15	-0.78	6.57	7.20	4.34	-0.28	11.85	10.16	20.11	32.87
Operating Cash Flow Less CapEx to Interest Expense	-6.20	-3.33	-2.89	131.81	-6.24	-2.84	-2.89	1.87	-3.21	6.86	19.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.35	0.32	0.33	0.32	0.32	0.33	0.36	0.40	0.43	0.48	0.45
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.40	0.00	0.00	7.14
Inventory Turnover	2.85	2.61	2.72	2.75	2.71	2.58	2.66	2.73	2.73	2.88	2.94
Fixed Asset Turnover	3.19	2.69	2.68	2.56	2.40	2.27	2.32	2.53	2.57	2.85	3.00
Accounts Payable Turnover	6.66	5.95	6.82	7.49	7.56	6.47	6.82	6.74	5.79	5.27	5.27
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	49.34	0.00	0.00	51.14
Days Inventory Outstanding (DIO)	127.89	139.60	133.97	132.96	134.76	141.71	137.30	133.75	133.46	126.69	124.31
Days Payable Outstanding (DPO)	54.80	61.36	53.55	48.72	48.26	56.37	53.48	54.13	63.06	69.30	69.22
Cash Conversion Cycle (CCC)	73.09	78.24	80.42	84.24	86.50	85.33	83.82	128.95	70.41	57.39	106.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,183	2,875	2,808	2,574	2,560	2,547	2,586	2,831	2,903	2,979	3,083
Invested Capital Turnover	0.72	0.57	0.57	0.58	0.58	0.52	0.55	0.61	0.67	0.76	0.88
Increase / (Decrease) in Invested Capital	-38	691	610	420	377	-329	-223	257	343	432	497
Enterprise Value (EV)	3,886	5,110	4,823	5,058	6,052	7,470	6,037	8,272	13,358	29,838	50,284
Market Capitalization	3,014	3,512	3,191	3,442	4,388	5,796	4,331	6,576	11,236	27,706	50,175
Book Value per Share	$19.65	$19.07	$17.46	$14.16	$13.18	$12.70	$12.71	$16.35	$11.17	$11.94	$41.64
Tangible Book Value per Share	$2.71	($7.57)	($8.42)	($10.59)	($10.87)	($10.53)	($9.84)	($5.64)	($10.17)	($8.62)	$21.63
Total Capital	4,127	4,099	3,679	3,461	3,476	3,443	3,452	3,708	4,024	4,134	6,255
Total Debt	2,817	2,821	2,502	2,503	2,580	2,571	2,573	2,573	3,244	3,287	3,282
Total Long-Term Debt	2,501	2,502	2,502	2,503	2,569	2,561	2,562	2,563	2,165	47	43
Net Debt	872	1,597	1,632	1,616	1,664	1,674	1,706	1,696	2,122	2,132	110
Capital Expenditures (CapEx)	58	31	19	-676	74	40	15	54	76	84	85
Debt-free, Cash-free Net Working Capital (DFCFNWC)	469	499	462	434	426	418	458	458	517	601	597
Debt-free Net Working Capital (DFNWC)	2,414	1,723	1,332	1,321	1,342	1,314	1,325	1,335	1,638	1,756	3,769
Net Working Capital (NWC)	2,098	1,404	1,332	1,321	1,331	1,305	1,314	1,325	559	-1,484	530
Net Nonoperating Expense (NNE)	11	25	47	159	25	25	18	-219	1.21	-26	-7.30
Net Nonoperating Obligations (NNO)	872	1,597	1,632	1,616	1,664	1,674	1,706	1,696	2,122	2,132	110
Total Depreciation and Amortization (D&A)	62	70	78	100	71	66	61	62	63	66	68
Debt-free, Cash-free Net Working Capital to Revenue	29.75%	34.71%	32.46%	31.92%	30.89%	29.54%	31.09%	27.84%	28.05%	28.52%	23.98%
Debt-free Net Working Capital to Revenue	152.98%	119.80%	93.72%	97.17%	97.34%	92.96%	89.95%	81.16%	88.95%	83.40%	151.46%
Net Working Capital to Revenue	132.97%	97.57%	93.72%	97.17%	96.56%	92.26%	89.25%	80.52%	30.37%	-70.51%	21.31%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.02)	($1.47)	($1.88)	($3.75)	($1.21)	($0.88)	($0.64)	$3.11	$0.06	$1.10	$1.99
Adjusted Weighted Average Basic Shares Outstanding	66.70M	67.20M	67.50M	67.30M	68.30M	68.90M	69.30M	69M	70.30M	71.10M	71.50M
Adjusted Diluted Earnings per Share	($1.02)	($1.47)	($1.88)	($3.75)	($1.21)	($0.88)	($0.64)	$3.10	$0.05	$0.89	$1.50
Adjusted Weighted Average Diluted Shares Outstanding	66.70M	67.20M	67.50M	67.30M	68.30M	68.90M	69.30M	69.60M	78.30M	87.80M	96.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	67M	67.40M	67.60M	68M	68.70M	69.20M	69.40M	69.90M	70.90M	71.40M	77.80M
Normalized Net Operating Profit after Tax (NOPAT)	-49	-70	-67	-68	-51	-36	-46	-2.24	12	52	138
Normalized NOPAT Margin	-15.38%	-18.97%	-18.22%	-21.98%	-15.11%	-8.86%	-10.77%	-0.47%	2.27%	7.78%	17.04%
Pre Tax Income Margin	-21.82%	-27.67%	-29.30%	-41.36%	-23.51%	-10.52%	-9.22%	-2.37%	0.97%	14.50%	22.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-6.14	-9.46	-10.93	-22.61	-13.40	-6.55	-5.88	-1.11	1.91	16.32	30.65
NOPAT to Interest Expense	-5.83	-7.59	-8.91	-17.29	-10.49	-6.45	-4.63	-1.09	0.95	8.27	22.08
EBIT Less CapEx to Interest Expense	-12.10	-12.64	-13.04	102.63	-26.84	-13.73	-8.49	-11.09	-11.46	3.06	16.90
NOPAT Less CapEx to Interest Expense	-11.79	-10.77	-11.02	107.95	-23.92	-13.63	-7.24	-11.07	-12.42	-4.98	8.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-39.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Lumentum (NASDAQ:LITE) based on the quarterly cash flow statements, income statements, and balance sheets over the last four years.

Net income turned positive in 2026-Q2, reaching $78.2 million, after a sequence of quarterly fluctuations. This marks a notable profitability improvement in the near term.
Cash from operating activities was solid in 2026-Q2, with net cash from continuing operating activities around $126.7 million, signaling stronger core cash generation.
Revenue rebounded to $665.5 million in 2026-Q2, up roughly 39% from late-2024 levels and showing continued top-line strength versus prior years.
Gross margin improved to about 36% in 2026-Q2 (gross profit $240.1 million on $665.5 million revenue), representing an improvement from some earlier quarters.
Liquidity remains robust, with cash and short-term investments totaling about $1.16 billion at 2026-Q2 (cash $657.7 million + short-term investments $497.6 million).
Balance sheet leverage remains high, with Total Liabilities around $3.96 billion and Total Equity of about $846.6 million in 2026-Q2, signaling substantial leverage and pressure on equity.
Working capital indicators show rising inventories and accounts receivable in 2026 (Inventories net $570.4 million; Accounts Receivable $376.8 million in 2026-Q2), suggesting greater working capital needs and potential cash-conversion timing considerations.
Capital expenditure activity remains ongoing (PPE purchases around $83.6 million in 2026-Q2), indicating continued investment in capacity and product development.
Profitability has remained volatile, with several quarters showing net losses in 2025 (for example, 2025-Q2 net income continuing operations about -$60.9 million and 2025-Q3 about -$44.1 million), underscoring ongoing earnings variability.

05/14/26 04:57 PM ETAI Generated. May Contain Errors.

Lumentum Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lumentum's financial year ends in June. Their financial year 2025 ended on June 28, 2025.

Lumentum's net income appears to be on a downward trend, with a most recent value of $25.90 million in 2025, falling from -$3.40 million in 2015. The previous period was -$546.50 million in 2024. View Lumentum's forecast to see where analysts expect Lumentum to go next.

Lumentum's total operating income in 2025 was -$180.10 million, based on the following breakdown:

Total Gross Profit: $459.90 million
Total Operating Expenses: $640 million

Over the last 10 years, Lumentum's total revenue changed from $837.10 million in 2015 to $1.65 billion in 2025, a change of 96.5%.

Lumentum's total liabilities were at $3.08 billion at the end of 2025, a 3.7% increase from 2024, and a 2,236.4% increase since 2015.

In the past 10 years, Lumentum's cash and equivalents has ranged from $14.50 million in 2015 to $1.29 billion in 2022, and is currently $520.70 million as of their latest financial filing in 2025.

Over the last 10 years, Lumentum's book value per share changed from 6.47 in 2015 to 16.35 in 2025, a change of 152.6%.

Related Companies

Financial statements for NASDAQ:LITE last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumentum (LITE) Financials

Financials Breakdown Chart

Key Financial Trends

Lumentum Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumentum (LITE) Financials

Annual Income Statements for Lumentum

Quarterly Income Statements for Lumentum

Annual Cash Flow Statements for Lumentum

Quarterly Cash Flow Statements for Lumentum

Annual Balance Sheets for Lumentum

Quarterly Balance Sheets for Lumentum

Annual Metrics And Ratios for Lumentum

Quarterly Metrics And Ratios for Lumentum

Financials Breakdown Chart

Key Financial Trends

Lumentum Financials - Frequently Asked Questions

When does Lumentum's fiscal year end?

How has Lumentum's net income changed over the last 10 years?

What is Lumentum's operating income?

How has Lumentum's revenue changed over the last 10 years?

How much debt does Lumentum have?

How much cash does Lumentum have?

How has Lumentum's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools